Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CENCOSUD.SN Stock Summary
In the News
CENCOSUD.SN Financial details
Company Rating
Buy
Market Cap
4776.68B
Income
220.28B
Revenue
14230.64B
Book val./share
1288
Cash/share
243.59
Dividend
103
Dividend %
6.37%
Employees
121.66K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
16.46
Forward P/E
7.86
PEG
-4.76
P/S
0.31
P/B
1.17
P/C
6.98
P/FCF
4.92
Quick Ratio
0.38
Current Ratio
0.81
Debt / Equity
1.48
LT Debt / Equity
1.12
-
-
EPS (TTM)
77.8
EPS next Y
216.32
EPS next Q
42.27
EPS this Y
-35.01%
EPS next Y
178.04%
EPS next 5Y
297.17%
EPS last 5Y
7.37%
Revenue last 5Y
8.31%
Revenue Q/Q
-13.72%
EPS Q/Q
197.96%
-
-
-
-
SMA20
-2.32%
SMA50
6.31%
SMA100
14.46%
Inst Own
0%
Inst Trans
0%
ROA
2%
ROE
8%
ROC
0.11%
Gross Margin
29%
Oper. Margin
7%
Profit Margin
2%
Payout
103%
Shs Outstand
2.83B
Shs Float
1.25B
-
-
-
-
Target Price
-
52W Range
1395.0-1920.0
52W High
-11.46%
52W Low
+21.86%
RSI
52
Rel Volume
5.94
Avg Volume
564.36K
Volume
3.35M
Perf Week
1.8%
Perf Month
0.06%
Perf Quarter
3.66%
Perf Half Y
3.34%
-
-
-
-
Beta
0.651
-
-
Volatility
11.13%, 35.61%
Prev Close
0.89%
Price
1700
Change
0.83%
CENCOSUD.SN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.34K | 3.45K | 4.13K | 4.99K | 4.99K | |
Net income per share | 54.16 | 22.76 | 165.6 | 119.1 | 77.3 | |
Operating cash flow per share | 267.69 | 401.85 | 428.01 | 119.1 | 467.17 | |
Free cash flow per share | 208.32 | 380.73 | 355.21 | -7.56 | 349.15 | |
Cash per share | 455.1 | 425.56 | 459.84 | 220.52 | 243.59 | |
Book value per share | 1.56K | 1.39K | 1.47K | 1.29K | 1.29K | |
Tangible book value per share | 1.2K | 1.1K | 1.16K | 644.98 | 571.97 | |
Share holders equity per share | 1.56K | 1.39K | 1.47K | 1.29K | 1.29K | |
Interest debt per share | 1.59K | 1.25K | 1.28K | 1.73K | 1.96K | |
Market cap | 2826.45B | 3611.58B | 4060.76B | 3969.83B | 4716.51B | |
Enterprise value | 6016.89B | 6214.04B | 6866B | 8423.41B | 9650.72B | |
P/E ratio | 18.28 | 55.58 | 8.6 | 11.71 | 21.41 | |
Price to sales ratio | 0.3 | 0.37 | 0.35 | 0.28 | 0.33 | |
POCF ratio | 3.7 | 3.15 | 3.33 | 11.71 | 3.54 | |
PFCF ratio | 4.75 | 3.32 | 4.01 | -184.5 | 4.74 | |
P/B Ratio | 0.64 | 0.91 | 0.97 | 1.08 | 1.28 | |
PTB ratio | 0.64 | 0.91 | 0.97 | 1.08 | 1.28 | |
EV to sales | 0.63 | 0.63 | 0.58 | 0.59 | 0.68 | |
Enterprise value over EBITDA | 11.44 | 12.83 | 8.44 | 11.73 | 14.09 | |
EV to operating cash flow | 7.87 | 5.42 | 5.63 | 24.85 | 7.25 | |
EV to free cash flow | 10.12 | 5.72 | 6.78 | -391.48 | 9.7 | |
Earnings yield | 0.05 | 0.02 | 0.12 | 0.09 | 0.05 | |
Free cash flow yield | 0.21 | 0.3 | 0.25 | -0.01 | 0.21 | |
Debt to equity | 0.96 | 0.83 | 0.86 | 1.32 | 1.48 | |
Debt to assets | 0.35 | 0.3 | 0.3 | 0.36 | 0.4 | |
Net debt to EBITDA | 6.07 | 5.37 | 3.45 | 6.2 | 7.2 | |
Current ratio | 1.27 | 1.09 | 1.06 | 0.83 | 0.78 | |
Interest coverage | 2.62 | 2.18 | 22.32 | 11.55 | 5.56 | |
Income quality | 6.7 | 50.03 | 2.58 | 1 | 6.04 | |
Dividend Yield | 0.01 | 0.03 | 0.17 | 0.09 | 0.06 | |
Payout ratio | 0.19 | 1.41 | 1.49 | 1.06 | 1.31 | |
Sales general and administrative to revenue | 0.22 | 0.2 | 0.18 | 0.19 | 0.23 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.13 | 0.13 | 0.12 | 0.18 | 0.2 | |
Capex to operating cash flow | -0.22 | -0.05 | -0.17 | -1.06 | -0.25 | |
Capex to revenue | -0.02 | -0.01 | -0.02 | -0.03 | -0.02 | |
Capex to depreciation | -0.53 | -0.16 | -0.74 | -0.99 | -0.79 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.38K | 842.52 | 2.34K | 1.86K | 1.5K | |
ROIC | 0.03 | 0.02 | 0.08 | 0.07 | 0.05 | |
Return on tangible assets | 0.01 | 0.01 | 0.04 | 0.03 | 0.02 | |
Graham Net | -1.68K | -1.47K | -1.64K | -2.45K | -2.54K | |
Working capital | 674.63B | 227.37B | 198.62B | -645.22B | -822.65B | |
Tangible asset value | 3437.95B | 3146.17B | 3309.28B | 1835.46B | 1630.03B | |
Net current asset value | 4046.56B | 3575.71B | 3856.85B | 5985.82B | 6319.22B | |
Invested capital | 0.96 | 0.83 | 0.86 | 1.32 | 1.48 | |
Average receivables | 959.57B | 719.84B | 716.31B | 884.85B | 920.09B | |
Average payables | 1960.65B | 2043.66B | 2381.69B | 2711.5B | 2696B | |
Average inventory | 1112.56B | 1004.24B | 1076.44B | 1380.06B | 1460.81B | |
Days sales outstanding | 30.85 | 23.48 | 24.83 | 24.92 | 22.33 | |
Days payables outstanding | 106.6 | 105.5 | 117.67 | 98.67 | 96.19 | |
Days of inventory on hand | 58.66 | 45.84 | 54.78 | 54.42 | 51.16 | |
Receivables turnover | 11.83 | 15.55 | 14.7 | 14.65 | 16.35 | |
Payables turnover | 3.42 | 3.46 | 3.1 | 3.7 | 3.79 | |
Inventory turnover | 6.22 | 7.96 | 6.66 | 6.71 | 7.14 | |
ROE | 0.03 | 0.02 | 0.11 | 0.09 | 0.06 | |
Capex per share | -59.37 | -21.12 | -72.8 | -126.66 | -118.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.38K | 1.25K | 1.28K | 1.34K | 1.16K | |
Net income per share | 50.45 | 21.54 | 17.34 | 9.8 | 29.22 | |
Operating cash flow per share | 50.45 | 21.54 | 0.11 | 382.16 | 262.46 | |
Free cash flow per share | 11.57 | 21.52 | 0.08 | 293.15 | 233.67 | |
Cash per share | 220.52 | 178.11 | 151.54 | 206.6 | 243.59 | |
Book value per share | 1.29K | 1.26K | 1.29K | 1.38K | 1.29K | |
Tangible book value per share | 644.98 | 655.13 | 646.54 | 672.42 | 571.97 | |
Share holders equity per share | 1.29K | 1.26K | 1.29K | 1.38K | 1.29K | |
Interest debt per share | 1.71K | 1.8K | 1.83K | 1.92K | 1.92K | |
Market cap | 3969.83B | 4303.75B | 4359.2B | 4810.65B | 4716.51B | |
Enterprise value | 8423.41B | 8897.76B | 9117.48B | 9876.2B | 9650.72B | |
P/E ratio | 6.91 | 17.82 | 22.4 | 42.97 | 14.16 | |
Price to sales ratio | 1.01 | 1.23 | 1.21 | 1.26 | 1.43 | |
POCF ratio | 27.65 | 71.29 | 14.74K | 4.41 | 6.31 | |
PFCF ratio | 120.54 | 71.39 | 20.66K | 5.75 | 7.08 | |
P/B Ratio | 1.08 | 1.22 | 1.2 | 1.22 | 1.28 | |
PTB ratio | 1.08 | 1.22 | 1.2 | 1.22 | 1.28 | |
EV to sales | 2.15 | 2.54 | 2.53 | 2.58 | 2.93 | |
Enterprise value over EBITDA | 29.63 | 38.11 | 51.55 | 62.03 | 39.21 | |
EV to operating cash flow | 58.67 | 147.39 | 30.83K | 9.05 | 12.9 | |
EV to free cash flow | 255.77 | 147.59 | 43.22K | 11.8 | 14.49 | |
Earnings yield | 0.04 | 0.01 | 0.01 | 0.01 | 0.02 | |
Free cash flow yield | 0.01 | 0.01 | 0 | 0.17 | 0.14 | |
Debt to equity | 1.32 | 1.41 | 1.41 | 1.38 | 1.48 | |
Debt to assets | 0.36 | 0.39 | 0.39 | 0.39 | 0.4 | |
Net debt to EBITDA | 15.67 | 19.68 | 26.91 | 31.82 | 20.05 | |
Current ratio | 0.83 | 0.83 | 0.84 | 0.81 | 0.78 | |
Interest coverage | 8.52 | 3.93 | 4.78 | 5.19 | 5.33 | |
Income quality | 1 | 1 | 0.01 | 38.99 | 8.98 | |
Dividend Yield | 0 | 0 | 0.07 | 0.06 | 0 | |
Payout ratio | 0 | 0 | 5.94 | 10.31 | 0 | |
Sales general and administrative to revenue | 0.19 | 0.21 | 0.21 | 0.22 | 0.21 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.18 | 0.18 | 0.19 | 0.2 | |
Capex to operating cash flow | -0.77 | 0 | -0.29 | -0.23 | -0.11 | |
Capex to revenue | -0.03 | 0 | 0 | -0.07 | -0.02 | |
Capex to depreciation | -1 | 0 | 0 | -2.3 | -0.81 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.21K | 781.96 | 710.08 | 552.35 | 920.24 | |
ROIC | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | |
Return on tangible assets | 0.01 | 0.01 | 0 | 0 | 0.01 | |
Graham Net | -2.45K | -2.39K | -2.47K | -2.57K | -2.54K | |
Working capital | -645.22B | -591.55B | -546.16B | -735.31B | -822.65B | |
Tangible asset value | 1835.46B | 1835.63B | 1813.77B | 1919.73B | 1630.03B | |
Net current asset value | 5985.82B | 5729.64B | 5977.12B | 6291.81B | 6319.22B | |
Invested capital | 1.32 | 1.41 | 1.41 | 1.38 | 1.48 | |
Average receivables | 957B | 933.95B | 881.83B | 876.57B | 879.09B | |
Average payables | 2688.08B | 2559B | 2351.31B | 2415.15B | 2580.42B | |
Average inventory | 1627.89B | 1489.74B | 1477.03B | 1565.14B | 1528.26B | |
Days sales outstanding | 22.25 | 23.08 | 21.61 | 20.89 | 23.75 | |
Days payables outstanding | 87.97 | 86.1 | 82.15 | 84.17 | 101.38 | |
Days of inventory on hand | 48.52 | 53.15 | 52.51 | 55.23 | 53.92 | |
Receivables turnover | 4.04 | 3.9 | 4.16 | 4.31 | 3.79 | |
Payables turnover | 1.02 | 1.05 | 1.1 | 1.07 | 0.89 | |
Inventory turnover | 1.85 | 1.69 | 1.71 | 1.63 | 1.67 | |
ROE | 0.04 | 0.02 | 0.01 | 0.01 | 0.02 | |
Capex per share | -38.88 | -0.03 | -0.03 | -89.01 | -28.79 |
CENCOSUD.SN Frequently Asked Questions
What is Cencosud S.A. stock symbol ?
Cencosud S.A. is a CL stock and trading under the symbol CENCOSUD.SN
What is Cencosud S.A. stock quote today ?
Cencosud S.A. stock price is $1700 today.
Is Cencosud S.A. stock public?
Yes, Cencosud S.A. is a publicly traded company.